Mvm Partners, LLC Opti Nose, Inc. Put Options Transaction History
Mvm Partners, LLC
- $99.9 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OPTN
# of Institutions
72Shares Held
85.2MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT13.7MShares$9.47 Million3.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT13.4MShares$9.26 Million0.93% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$3.86 Million0.68% of portfolio
-
Black Rock Inc. New York, NY5.27MShares$3.64 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5MShares$3.45 Million0.01% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $57.5M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...